Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

A non-reactive result in an HIV test generally means that you don't have HIV. It may also mean you tested too soon after ...

At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?

HIV testing, STD screening and community education programs are all at risk of ending in LA County when federal funds expire at the end of May; ... The Los Angeles County Department of Public Health ...

This label, while designed to capture risk, ends up pathologizing identity instead of behavior, and only further undermines ...

Africa is currently engulfed in a wave of complex epidemiological transition that is characterized by extensive urbanization with concomitant lifestyle changes such as consumption of calorie dense ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

According to the CDC, Georgia had the second-highest HIV diagnosis rate and the second-highest rate of HIV-related deaths in 2023 in the U.S.. Georgia had the highest rate of new HIV infections in ...

But, the gender gap in HIV testing has the potential to fuel undetected infections. The latest Zimbabwe Demographic and Health Survey (ZDHS) 2023-2024 reveals a troubling paradox: Although HIV ...